Pharmaceuticals (trbc) articles
-
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by SRS Capital Advisors Inc.
SRS Capital Advisors Inc. boosted its position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 5.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,283 shares of the medical instruments supplier’s stock after buying an additional 64 shares during the period. SRS Capital Advisors Inc.’s holdings in West Pharmaceutical Services were worth […]
-
Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
CAMBRIDGE, Mass., May 02, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2024 and reviewed recent business highlights.
-
Alnylam Pharmaceuticals (NASDAQ:ALNY) Posts Quarterly Earnings Results, Beats Estimates By $0.23 EPS
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) released its earnings results on Thursday. The biopharmaceutical company reported ($0.52) earnings per share for the quarter, beating the consensus estimate of ($0.75) by $0.23, Briefing.com reports. The firm had revenue of $494.33 million during the quarter, compared to the consensus estimate of $428.01 million. During the same […]